Selpercatinib is a select inhibitor that goes after RET kinase it attacks RET-fusion-positive non-small cell lung cancer, or NSCLC, along with medullary thyroid cancer and other RET-altered tumors. There are two doses: 40 mg or 80 mg these come in capsules, and you’re supposed to take 160 mg, twice a day, you don’t have to eat before taking it.
Each bottle has 60 capsules.
Reviews
There are no reviews yet.